It was access, access, access, as Jack Shafer reminds us.
And, that drug is as addicting inside the Beltway to the editorial side of newsrooms as it is to the business/marketing wing. That’s why, at the Washington Post, Executive Editor Marcus Brauchli apparently signed off at first. It was only after he realized that this drug “access” would only be dispensed by the business side that he got all huffy.
No comments:
Post a Comment